CIFR
Cipher Mining Inc.
There isn't enough reported data to score CIFR yet.
MPT
Medical Properties Trust, Inc.
There isn't enough reported data to score MPT yet.
CIFR Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| N/A | |
| N/A |
CIFR's revenue and profitability are currently weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like CIFR.
MPT Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
MPT's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like MPT.
CIFR PE Valuation
CIFR has no meaningful PE right now: it lost money over the past year.
MPT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.2x | $1.71 | โ |
| Cheap | 7.1x | $2.90 | +70% |
| Fair | 22x | $8.96 | +424% |
| Expensive | 26x | $10.48 | +513% |
Historical ranges are pointers, not guarantees.
MPT's PE is 4.2x, but its earnings don't support one, so it isn't a reliable read right now.
CIFR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
CIFR has the edge over MPT on the outlook, with more favorable earnings and revenue expectations.
MPT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect MPT's earnings and profitability to decline, with its revenue holding steady.
CIFR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.06 | -$2.86 |
| Q2 2026 | -$2.85 | -$2.40 |
| Q1 2026 | -$2.32 | -$1.94 |
| Q4 2025 | -$2.15 | -$2.01 |
| Q3 2025 | -$0.20 | -$0.07 |
| Q2 2025 | -$0.45 | -850% |
| Q1 2025 | -$0.38 | -733% |
| Q4 2024 | -$0.14 | -$0.04 |
CIFR lost $3.06 per share over the past year, and its loss has widened in each of the last four quarters.
MPT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.41 | +$1.58 |
| Q2 2026 | -$0.06 | +$2.32 |
| Q1 2026 | -$0.21 | +$2.55 |
| Q4 2025 | -$0.46 | +$3.56 |
| Q3 2025 | -$1.17 | +$3.28 |
| Q2 2025 | -$2.38 | +$0.54 |
| Q1 2025 | -$2.76 | -$0.31 |
| Q4 2024 | -$4.02 | -$3.08 |
MPT has the edge over CIFR on earnings quality, reporting a profit while its opponent remains loss making.
CIFR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.7M | -63% |
| Q2 2026 | $24.8M | -43% |
| Q1 2026 | $34.8M | -29% |
| Q4 2025 | $59.7M | +41% |
| Q3 2025 | $71.7M | +198% |
| Q2 2025 | $43.6M | +18% |
| Q1 2025 | $49M | +1.7% |
| Q4 2024 | $42.2M | -2.8% |
CIFR's revenue has slid since its 2025 peak: $27M last quarter, down 63% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -269% | -217 points |
| Q2 2026 | -316% | -212 points |
| Q1 2026 | -329% | -251 points |
| Q4 2025 | -503% | -544 points |
| Q3 2025 | -52% | +327 points |
| Q2 2025 | -104% | -60 points |
| Q1 2025 | -78% | -175 points |
| Q4 2024 | 40% | +4 points |
CIFR's operating margin was โ269% last quarter, down 217 points from the same quarter a year ago.
MPT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $250.1M | +5.3% |
| Q2 2026 | $259.3M | +7.9% |
| Q1 2026 | $252.1M | +13% |
| Q4 2025 | $270.3M | +17% |
| Q3 2025 | $237.5M | +5.2% |
| Q2 2025 | $240.4M | -9.8% |
| Q1 2025 | $223.8M | -18% |
| Q3 2024 | $225.8M | -26% |
MPT has the edge over CIFR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.5% | -1.9 points |
| Q2 2026 | 3.3% | +0.5 points |
| Q1 2026 | 2.7% | +5.2 points |
| Q4 2025 | 14% | +1.8 points |
| Q3 2025 | -3.6% | +53 points |
| Q2 2025 | 2.9% | -4.6 points |
| Q1 2025 | -2.5% | -21 points |
| Q4 2024 | 12% | N/A |
MPT has the edge over CIFR on profitability, with a higher operating margin.
CIFR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.7B | -$1.4B |
| Q2 2026 | -$653.8M | -$566.3M |
| Q1 2026 | -$462.5M | -$390.7M |
| Q4 2025 | -$280.3M | -$204.2M |
| Q3 2025 | -$256.2M | -$173.1M |
| Q2 2025 | -$87.5M | -$54.3M |
| Q1 2025 | -$71.8M | -$37.3M |
| Q4 2024 | -$76.1M | +$38M |
CIFR's free cash flow was โ$3.1B over the past year, against โ$492M the year before. Free cash flow isn't a meaningful measure for financial services companies like CIFR.
MPT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $41.1M | +122% |
| Q2 2026 | $62.4M | +21% |
| Q1 2026 | -$14.3M | -3813% |
| Q4 2025 | $160.1M | +109% |
| Q3 2025 | $18.6M | -69% |
| Q2 2025 | $51.7M | +47% |
| Q1 2025 | $384K | -99% |
| Q4 2024 | $76.7M | -43% |
MPT has the edge over CIFR on cash generation, producing positive trailing cash flow while its opponent burns cash.
CIFR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2025 | -2.3x | Net Cash |
| Q1 2025 | 125.4x | High |
| Q4 2024 | 0.5x | Very low |
| Q3 2024 | -0.7x | Net Cash |
| Q2 2024 | -1.2x | Net Cash |
| Q1 2024 | -0.9x | Net Cash |
| Q4 2023 | -2.2x | Net Cash |
| Q2 2023 | -0.1x | Net Cash |
CIFR has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like CIFR.
MPT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 27.0x | High |
| Q2 2026 | 28.8x | High |
| Q1 2026 | 29.0x | High |
| Q4 2025 | 30.7x | High |
| Q3 2025 | 32.3x | High |
| Q2 2025 | 30.0x | High |
| Q1 2025 | 24.9x | High |
| Q4 2024 | 20.3x | High |
MPT's net debt is more than 20 years of its operating earnings (EBITDA), down from more than 20 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MPT.
CIFR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 7.8 | Oversold |
CIFR's weekly RSI is 34 (neutral) and its Stochastic is 8 (oversold).
MPT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 14.7 | Oversold |
| Stochastic | 2.8 | Oversold |
MPT's weekly RSI is 15 (oversold) and its Stochastic is 3 (oversold).
CIFR PE vs Financial Services Sector
| Metric | CIFR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | โ |
CIFR has no meaningful PE right now: it lost money over the past year.
MPT PE vs Financial Services Sector
| Metric | MPT | Sector median | Relative |
|---|---|---|---|
| PE | 4.2x | 13x | 68% below |
| PE % | 0 | 63 | 63 pts below |
MPT is trading at 4.2x earnings, a 68% discount to the Financial Services sector's median of 13x, though its earnings don't support one.
CIFR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.6 | 33% below |
| 20 week MA | $15.5 | 54% below |
| 50 week MA | $17.0 | 58% below |
| 100 week MA | $12.2 | 41% below |
| 200 week MA | $7.86 | 9% below |
CIFR is in a downtrend: it's below all five of its weekly moving averages, and 9% below its 200-week average.
MPT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.68 | 36% below |
| 20 week MA | $3.65 | 53% below |
| 50 week MA | $4.51 | 62% below |
| 100 week MA | $4.68 | 63% below |
| 200 week MA | $5.44 | 69% below |
MPT is in a downtrend: it's below all five of its weekly moving averages, and 69% below its 200-week average.
CIFR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.92 | $9.95 | +0.3% |
| 2021 | $9.95 | $5.21 | -48% |
| 2022 | $5.21 | $0.54 | -90% |
| 2023 | $0.54 | $4.13 | +665% |
| 2024 | $4.13 | $4.86 | +18% |
| 2025 | $4.86 | $15.2 | +213% |
| 2026 YTD | $15.2 | $7.15 | -53% |
CIFR has the edge over MPT on returns for 2026, with the stronger performance.
MPT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.7 | $21.7 | +4.9% |
| 2021 | $21.7 | $22.7 | +4.3% |
| 2022 | $22.7 | $11.2 | -51% |
| 2023 | $11.2 | $4.91 | -56% |
| 2024 | $4.91 | $3.73 | -24% |
| 2025 | $3.73 | $5.08 | +36% |
| 2026 YTD | $5.08 | $1.71 | -66% |
MPT has finished lower in three of the last six years. It's down 66% so far in 2026.